[email protected]
We established a quick response research team to monitor the impacts of global pandemic COVID19 on this market to keep our clients informed about latest data and changing strategies. The report will incorporate these insight and data factors. | × |
---|
2019-06-18
310
Global
Neurology is still a complicated segment and thus the neurological biomarkers application is growing at high rate among not only the clinical practitioners but also for the experimental purposes. Increasing usage of metabolomics, proteomics, genomics, and bioinformatics along with the advanced technologies and investments from the government and private players is driving the growth of the market. Further, obesity is one the major cause in the development of diseases and other problems in the central nervous system (CNS). As per WHO, globally 1.4 billion adults are overweight with highest population in the developed and developing countries. Rate of obesity is growing at a fast pace in the developing countries. Moreover, the diagnostic application of neurological biomarkers is facing slow growth as compared to high rate of drug discovery and development applications. The personalized medication is a new trend in the application of neurological biomarker. Moreover, the personalized medication using biomarkers are witnessing tremendous positive outcomes in the cases of neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease (PD).
Our Global Neurological Biomarker Market can be segmented on the following basis:
By Type
By Product Type
By Application
By End-User
Global Neurological Biomakers Market Outlook comprises of the following data:
In 2016 on the basis of application, drug discovery and development segment accounted for largest market share due to increasing number of Neurodegenerative Disease cases. Knowing the root cause of the disease and its solution is most effective by the use of personalized medication using biomarkers.
Multiple sclerosis (MS) is a deep-rooted disorder of the CNS. Among the young adults it is the most common cause of neurological disability majorly in the Northern Europe, North America, and similar temperate latitudes. The course of medication is difficult to perform and thus the surrogate endpoints prove to be very useful to carry out clinical trials and course of medication.
For a full detailed overview, send us the sample request.
Reasons to buy this market study
A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements
A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements
OR Call Us:+1-646-568-7747Global Point of Care Testing (POCT) Devices Market Outlook 2024: Global Opportunity , Market Segmentation By Systems Basis, By Clinical Specialties & Diseases, By Areas of Use, By End User & by Region with Forecast 2017-2030
Global Home Healthcare Equipment Market Size , Share, By Device, By Distribution Channel, By End User & by Region with Forecast 2017-2030
Global Connected Healthcare Market Analysis by type, by function & by application with regional outlook and forecast to 2030
India In-Vitro Diagnostics (IVD) Market Outlook 2024, Global Opportunity and Demand Analysis, Market Forecast, 2016-2024
Global Connected Medical Device Market Outlook 2024, Global Opportunity and Demand Analysis, Market Forecast, 2016-2024